Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated
with estimates of treatment effects in controlled trials. JAMA.1995;273:408-412.
Moher D, Pham B, Jones A.
et al. Does the quality of reports of randomised trials affect estimates of
intervention efficacy reported in meta-analyses? Lancet.1998;352:609-613.
Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R. Treatment of Attention-Deficit/Hyperactivity Disorder. Hamilton, Ontario: McMaster University; 2000. Evidence Report/Technology
Assessment No. 11.
Thornley B, Adams CE. Content and quality of 2000 controlled trials in schizophrenia over
50 years. BMJ.1998;317:1181-1184.
Hotopf M, Lewis G, Normand C. Putting trials on trial: the costs and consequences of small trials
in depression: a systematic review of methodology. J Epidemiol Community Health.1997;51:354-358.
Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I. Size and quality of randomised controlled trials in head injury: review
of published studies. BMJ.2000;320:1308-1311.
Begg CB, Cho MK, Eastwood S.
et al. Improving the quality of reporting of randomized controlled trials:
the CONSORT statement. JAMA.1996;276:637-639.
Freemantle N, Mason JM, Haines A, Eccles MP. CONSORT: an important step toward evidence-based health care. Ann Intern Med.1997;126:81-83.
Altman DG. Better reporting of randomized controlled trials: the CONSORT statement. BMJ.1996;313:570-571.
Schulz KF. The quest for unbiased research: randomized clinical trials and the
CONSORT reporting guidelines. Ann Neurol.1997;41:569-573.
Huston P, Hoey J. CMAJ endorses the CONSORT statement. CMAJ.1996;155:1277-1279.
Davidoff F. News from the International Committee of Medical Journal Editors. Ann Intern Med.2000;133:229-231.
Moher D, Jones A, Lepage L.for the CONSORT Group. Use of the CONSORT statement and quality of reports of randomized trials:
a comparative before-and-after evaluation. JAMA.2001;285:1992-1995.
Egger M, Jüni P, Bartlett C.for the CONSORT Group. Value of flow diagrams in reports of randomized controlled trials. JAMA.2001;285:1996-1999.
Meinert CL. Beyond CONSORT: need for improved reporting standards for clinical
Chalmers I. Current controlled trials: an opportunity to help improve the quality
of clinical research. Curr Control Trials Cardiovasc Med.2000;1:3-8.
Bailer III JC, Mosteller F. Guidelines for statistical reporting in articles for medical journals:
amplifications and explanations. Ann Intern Med.1988;108:266-273.
Altman DG, Schulz KF, Moher D.
et al. for the CONSORT group. The revised CONSORT statement for reporting randomized trials: explanation
and elaboration. Ann Intern Med.2001;134:663-694.
Elbourne DR, Campbell MK. Extending the CONSORT statement to cluster randomised trials: for discussion. Stat Med.2001;20:489-496.
Hollis S, Campbell F. What is meant by intention-to-treat analysis? survey of published randomized
controlled trials. BMJ.1999;319:670-674.
Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J. Intention-to-treat analysis is related to methodological quality. BMJ.2000;320:1007-1008.
Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of clinical trials by treatment actually received: is it really
an option? Stat Med.1991;10:1595-1605.
Bentzen SM. Towards evidence based radiation oncology: improving the design, analysis,
and reporting of clinical outcome studies in radiotherapy. Radiother Oncol.1998;46:5-18.
O'Toole LB. MRC uses checklist similar to CONSORT's. BMJ.1997;314:1127.
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF.for the QUOROM group. Improving the quality of reports of meta-analyses of randomized controlled
trials: the QUOROM statement. Lancet.1999;354:1896-1900.
Stroup DF, Berlin JA, Morton SC.
et al. Meta-analysis of observational studies in epidemiology: a proposal
for reporting. JAMA.2000;283:2008-2012.
Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analysis. JAMA.1996;276:1339-1341.
Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The Quality of Reporting in Published Cost-Utility Analyses, 1976-1997. Ann Intern Med.2000;132:964-972.
Altman DG. The scandal of poor medical research. BMJ.1994;308:283-284.